369 related articles for article (PubMed ID: 17962208)
1. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.
Révillion F; Lhotellier V; Hornez L; Bonneterre J; Peyrat JP
Ann Oncol; 2008 Jan; 19(1):73-80. PubMed ID: 17962208
[TBL] [Abstract][Full Text] [Related]
2. The complete family of epidermal growth factor receptors and their ligands are co-ordinately expressed in breast cancer.
McIntyre E; Blackburn E; Brown PJ; Johnson CG; Gullick WJ
Breast Cancer Res Treat; 2010 Jul; 122(1):105-10. PubMed ID: 19760033
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of epidermal growth factor receptor 4 in oral leukoplakia.
Kobayashi H; Kumagai K; Gotoh A; Eguchi T; Yamada H; Hamada Y; Suzuki S; Suzuki R
Int J Oral Sci; 2013 Mar; 5(1):14-20. PubMed ID: 23492901
[TBL] [Abstract][Full Text] [Related]
4. Increased concentrations of growth factors and activation of the EGFR system in breast cancer.
Olsen DA; Bechmann T; Østergaard B; Wamberg PA; Jakobsen EH; Brandslund I
Clin Chem Lab Med; 2012 Oct; 50(10):1809-18. PubMed ID: 23089711
[TBL] [Abstract][Full Text] [Related]
5. Amphiregulin exosomes increase cancer cell invasion.
Higginbotham JN; Demory Beckler M; Gephart JD; Franklin JL; Bogatcheva G; Kremers GJ; Piston DW; Ayers GD; McConnell RE; Tyska MJ; Coffey RJ
Curr Biol; 2011 May; 21(9):779-86. PubMed ID: 21514161
[TBL] [Abstract][Full Text] [Related]
6. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF
J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723
[TBL] [Abstract][Full Text] [Related]
7. Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells.
Oliveras-Ferraros C; Cufí S; Queralt B; Vazquez-Martin A; Martin-Castillo B; de Llorens R; Bosch-Barrera J; Brunet J; Menendez JA
Br J Cancer; 2012 Apr; 106(8):1406-14. PubMed ID: 22491422
[TBL] [Abstract][Full Text] [Related]
8. EGF-like growth factors induce COX-2-derived PGE2 production through ERK1/2 in human granulosa cells.
Fang L; Cheng JC; Chang HM; Sun YP; Leung PC
J Clin Endocrinol Metab; 2013 Dec; 98(12):4932-41. PubMed ID: 24092824
[TBL] [Abstract][Full Text] [Related]
9. ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4.
Wang LM; Kuo A; Alimandi M; Veri MC; Lee CC; Kapoor V; Ellmore N; Chen XH; Pierce JH
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6809-14. PubMed ID: 9618494
[TBL] [Abstract][Full Text] [Related]
10. Expression and regulation of c-ERBB ligands in human head and neck squamous carcinoma cells.
O-Charoenrat P; Rhys-Evans P; Eccles S
Int J Cancer; 2000 Dec; 88(5):759-65. PubMed ID: 11072245
[TBL] [Abstract][Full Text] [Related]
11. ErbB signaling regulates lineage determination of developing pancreatic islet cells in embryonic organ culture.
Huotari MA; Miettinen PJ; Palgi J; Koivisto T; Ustinov J; Harari D; Yarden Y; Otonkoski T
Endocrinology; 2002 Nov; 143(11):4437-46. PubMed ID: 12399441
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of EGF receptor and its ligands, AREG, EREG, and HB-EGF in oral lichen planus.
Kumagai K; Horikawa T; Gotoh A; Yamane S; Yamada H; Kobayashi H; Hamada Y; Suzuki S; Suzuki R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Dec; 110(6):748-54. PubMed ID: 20952227
[TBL] [Abstract][Full Text] [Related]
13. The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced.
Sørensen BS; Tørring N; Bor MV; Nexø E
Mol Cell Biochem; 2004 May; 260(1-2):129-35. PubMed ID: 15228094
[TBL] [Abstract][Full Text] [Related]
14. EGFR and EGFR ligands in serum in healthy women; reference intervals and age dependency.
Kjær IM; Olsen DA; Alnor A; Brandslund I; Bechmann T; Madsen JS
Clin Chem Lab Med; 2019 Nov; 57(12):1948-1955. PubMed ID: 31323001
[TBL] [Abstract][Full Text] [Related]
15. Expression of the ERBB Family of Ligands and Receptors in Gastric Cancer.
Byeon SJ; Lee HS; Kim MA; Lee BL; Kim WH
Pathobiology; 2017; 84(4):210-217. PubMed ID: 28399526
[TBL] [Abstract][Full Text] [Related]
16. Possible autocrine loop of the epidermal growth factor system in patients with benign prostatic hyperplasia treated with finasteride: a placebo-controlled randomized study.
Tørring N; Møller-Ernst Jensen K; Lund L; Nielsen JE; Djurhuus JC; Poulsen SS; Nexø E
BJU Int; 2002 Apr; 89(6):583-90. PubMed ID: 11942969
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
[TBL] [Abstract][Full Text] [Related]
18. Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostate.
Adam RM; Borer JG; Williams J; Eastham JA; Loughlin KR; Freeman MR
Endocrinology; 1999 Dec; 140(12):5866-75. PubMed ID: 10579352
[TBL] [Abstract][Full Text] [Related]
19. Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression.
el-Marjou A; Delouvée A; Thiery JP; Radvanyi F
Carcinogenesis; 2000 Dec; 21(12):2211-8. PubMed ID: 11133810
[TBL] [Abstract][Full Text] [Related]
20. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
